AEON · AEON Biopharma, Inc. · Documents
$0.23
+0.00 (+0.74%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result of these conditions, management has concluded that substantial doubt about our ability to continue as a going concern exists as conditions and events, considered in the aggregate, indicate that it is probable that we will be unable to meet our obligations as they become due within one year after the date that the financial statements included in this Report are issued.”View the 10-Q filed Aug 12, 2026
Market Cap
$11.80M
Shares
49.88M
Volume · Oct 20
300.7K
Avg daily vol (3M)
7.53M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| PRE 14A | AEON Biopharma, Inc. will ask stockholders on December 15, 2026 to authorize one reverse stock split from 1-for-2 through 1-for-100 within 12 months, and add pre-funded warrant shares to evergreen calculations for its incentive plan and employee stock purchase plan. | 2026-10-13 | — | |
| 8-K | — | 2026-09-30 | — | |
| 8-K | — | 2026-08-12 | — | |
| 10-Q | — | 2026-08-12 | 2026-06-30 | |
| 8-K | — | 2026-08-03 | — | |
| 8-K | — | 2026-07-23 | — | |
| 8-K | — | 2026-07-15 | 2026-07-13 | |
| S-1/A | — | 2026-07-09 | — | |
| S-1 | — | 2026-07-08 | — | |
| 8-K | — | 2026-06-17 | — | |
| 10-Q | — | 2026-05-14 | 2026-03-31 | |
| 8-K | — | 2026-05-14 | — | |
| 8-K | — | 2026-05-14 | — | |
| DEFA14A | — | 2026-04-29 | — | |
| ARS | — | 2026-04-29 | 2025-12-31 | |
| DEF 14A | — | 2026-04-29 | — | |
| 8-K | — | 2026-04-03 | 2026-03-31 | |
| 8-K | — | 2026-03-30 | — | |
| 10-K | — | 2026-03-30 | 2025-12-31 | |
| 8-K | — | 2026-03-09 | 2026-03-06 | |
| S-3 | — | 2026-02-09 | — | |
| 8-K | — | 2026-01-21 | — | |
| 8-K | — | 2026-01-12 | — | |
| DEF 14A | — | 2025-12-29 | — | |
| PRE 14A | — | 2025-12-19 | — | |
| 8-K | — | 2025-12-15 | — | |
| 8-K | — | 2025-12-04 | — | |
| DEFA14A | — | 2025-11-14 | — | |
| 10-Q | — | 2025-11-14 | 2025-09-30 | |
| 8-K | — | 2025-11-14 | — | |
| DEFA14A | — | 2025-11-13 | — | |
| 8-K | — | 2025-11-13 | 2025-11-12 | |
| 8-K | — | 2025-09-08 | — | |
| 10-Q | — | 2025-08-12 | 2025-06-30 | |
| 8-K | — | 2025-08-12 | — | |
| 8-K | — | 2025-06-13 | — | |
| DEFR14A | — | 2025-06-11 | — | |
| 10-Q/A | — | 2025-06-11 | 2025-03-31 | |
| 10-K/A | — | 2025-06-11 | 2024-12-31 | |
| 8-K | — | 2025-05-20 | — | |
| 10-Q | — | 2025-05-14 | 2025-03-31 | |
| 8-K | — | 2025-05-14 | — | |
| ARS | — | 2025-04-29 | 2024-12-31 | |
| DEF 14A | — | 2025-04-29 | 2024-12-31 | |
| 8-K | — | 2025-04-25 | 2025-04-22 | |
| 8-K | — | 2025-04-21 | 2025-04-19 | |
| 8-K | — | 2025-04-08 | 2025-04-03 | |
| 8-K | — | 2025-03-27 | 2025-03-24 | |
| 10-K | — | 2025-03-24 | 2024-12-31 | |
| 8-K | — | 2025-03-24 | — |
Showing 1–50 of 171 filings